First Cohort Shows Many Routes To US FDA’s Commissioner’s National Priority Voucher

 
• By Sarah Karlin-Smith
  
A wide range of drugs were included in the first group of Commissioner's National Priority Voucher recipients. (Shutterstock)

More from US FDA

More from Agency Leadership